Dr Richard Faint is Head of Content, leading the medical device and diagnostics, and consumer health teams, who together bring diverse clinical, commercial, and regulatory experience to deliver clear and innovative business solutions to clients. Richard has clinical and commercial experience gained from hospital practice, the pharmaceutical industry, and working with market research and consultancy firms.
Richard joined Pharma Intelligence via Datamonitor Ltd in 2003 as the Director of Oncology Analysis, and then as Director of Therapy Analysis. Richard creates and delivers successful business products and services using financial and clinical data, epidemiology, electronic medical records and primary research.
Before joining Datamonitor and Pharma Intelligence, Richard worked in different roles for over 10 years at a UK biophamaceutical company specializing in the discovery and development of novel molecules targeting cancer. Richard has experience in laboratory and developmental diagnostics, in cancer chemotherapy, using targeted therapies in angiogenesis and metastases, as well as immunology and cardiovascular disease. With an MBA (OUBS) and a PhD in cell signalling mechanisms (UCL), Richard is excited by the scientific and clinical advances that continue to deliver deeper understanding and new treatments for life-threatening diseases.
